TD Cowen Upgrades Extendicare to Buy, Raises Price Target to C$32

Benzinga Newsdesk www.benzinga.com Positive 86.8%

Neg 0% Neu 0% Pos 86.8%

TD Cowen analyst Jonathan Kelcher upgrades Extendicare (TSX:EXE) from Hold to Buy and raises the price target from C$19 to C$32.